Beljanski Foundation spotlights research on cancer stem cells ahead of Survivors Day

The Beljanski Foundation is highlighting new research on cancer stem cells and plant-derived compounds ahead of National Cancer Survivors Day, with findings set to be shared at a June 26-29 integrative cancer conference in San Diego. The work is aimed at reducing recurrence risk and expanding long-term survivorship strategies.

Why it matters: - Cancer recurrence remains a major concern for survivors and care teams even after treatment success. - Research aimed at cancer stem cells could help explain why some tumors return and may point to new ways to prevent relapse. - The Beljanski Foundation is framing plant-derived compounds as part of an integrative approach that could support longer-term cancer care.

What happened: - The Beljanski Foundation is highlighting new findings ahead of National Cancer Survivors Day on June 7. - The research focuses on the role of cancer stem cells in tumor recurrence and the potential of botanical compounds against those cells. - The findings will be presented at the Beljanski Integrative Cancer Conference on June 26-29, 2026, in San Diego. - The conference is designed for healthcare professionals, researchers, patients and caregivers.

The details: - Cancer stem cells are considered a challenge in oncology because they can survive conventional treatment, resist chemotherapy and contribute to relapse. - The foundation-funded research explored botanical compounds that showed activity against cancer stem cells. - The conference will bring together physicians, researchers and integrative oncology experts to discuss cancer research and cancer care. - Sylvie Beljanski, founder and president of The Beljanski Foundation, said recurrence remains one of the greatest concerns for patients and healthcare providers. - Beljanski said research targeting cancer stem cells is an important frontier because it aims to eradicate the disease through a more comprehensive and natural approach. - Beljanski will present new research findings at the conference. - A portion of conference proceeds will fund a new research program focused on prostate cancer stem cells. - More information is available on the conference website.

Between the lines: - The foundation is positioning survivorship research as the next stage of oncology progress, not just initial treatment response. - The emphasis on integrative oncology suggests a push to connect laboratory findings with practical care options that clinicians can discuss with patients. - The focus on prostate cancer stem cells hints at a targeted next research step rather than a broad, general expansion.

What’s next: - The conference is expected to serve as the main venue for unveiling the new findings and building collaboration across disciplines. - Funds raised through the event will support additional research on prostate cancer stem cells. - The foundation said its broader research and education efforts will continue to center on non-toxic approaches to health and cancer care.